Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pulmonary Fungal Diseases”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT07706972
What this trial is testing

COPD-PTB Screening Trial in Henan, China

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)TB - Tuberculosis
Henan Provincial People's Hospital 25,000
Not applicableStudy completedNCT01379040
What this trial is testing

Volatile Organic Compounds in Cystic Fibrosis

Who this might be right for
Cystic FibrosisPseudomonas Aeruginosa
Landon Pediatric Foundation 24
Not applicableStudy completedNCT02689531
What this trial is testing

CTTI Risk Factors for HABP/VABP Study

Who this might be right for
Pneumonia, Ventilator-AssociatedPneumonia, BacterialPneumonia, Hospital-Acquired
Duke University 7,530
Testing effectiveness (Phase 2)UnknownNCT04768231
What this trial is testing

Rifampicin at High Dose for Difficult-to-Treat Tuberculosis

Who this might be right for
Tuberculosis
Hospital Universitari Vall d'Hebron Research Institute 130
Not applicableStudy completedNCT04818853
What this trial is testing

COVID-19 Associated Pulmonary Aspergillosis (CAPA) and Other Invasive Fungal Infections (IFI)

Who this might be right for
Covid19AspergillosisFungal Infection
University of Alabama at Birmingham 219
Testing effectiveness (Phase 2)Study completedNCT02371681
What this trial is testing

NexGen EBA Radiologic and Immunologic Biomarkers of Sterilizing Drug Activity in Tuberculosis

Who this might be right for
Pulmonary Tuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 262
Large-scale testing (Phase 3)Study completedNCT00311298
What this trial is testing

Nutrition, Diabetes and Pulmonary TB/HIV

Who this might be right for
TuberculosisHIVDiabetes
University of Copenhagen 1,250
Large-scale testing (Phase 3)UnknownNCT01798537
What this trial is testing

Simplified Selective Digestive Tract Decontamination for the Prevention of Intensive Care Unit Acquired Infections

Who this might be right for
Bacteremia Associated With Intravascular LineVentilator Associated PneumoniaBacteremia
Rambam Health Care Campus 2,400
Testing effectiveness (Phase 2)Study completedNCT01215110
What this trial is testing

Evaluation of Early Bactericidal Activity in Pulmonary Tuberculosis (TMC207-CL001)

Who this might be right for
Pulmonary Tuberculosis
Global Alliance for TB Drug Development 68
Large-scale testing (Phase 3)Active Not RecruitingNCT06081361
What this trial is testing

Innovating Shorter, All- Oral, Precised, Individualized Treatment Regimen for Rifampicin Resistant Tuberculosis：Contezolid, Delamanid and Bedaquiline Cohort

Who this might be right for
Pulmonary TuberculosisRifampicin-resistant Tuberculosis
Beijing Chest Hospital 186
Large-scale testing (Phase 3)Ended earlyNCT00302341
What this trial is testing

DB289 Versus TMP-SMX for the Treatment of Acute Pneumocystis Jiroveci Pneumonia (PCP)

Who this might be right for
Pneumonia, Interstitial Plasma CellPneumocystis Carinii PneumoniaPneumonia, Pneumocystis Carinii+1 more
Immtech Pharmaceuticals, Inc 48
Not applicableStudy completedNCT03034642
What this trial is testing

Modulation of Steroid Immunosuppression by Alveolar Efferocytosis

Who this might be right for
Pulmonary Disease, Chronic ObstructivePneumonia, Bacterial
VA Ann Arbor Healthcare System 60
Testing effectiveness (Phase 2)Study completedNCT01969799
What this trial is testing

Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia

Who this might be right for
Pneumonia, Bacterial
Cardeas Pharma 143
Not applicableLooking for participantsNCT06966284
What this trial is testing

A Post-Marketing Study to Assess the Efficacy and Safety of Intravenous Polymyxin B and Colistin Methanesulfonate in Patients With Carbapenem-Resistant Gram-Negative Bacterial Infection

Who this might be right for
Bacteremia Caused by Gram-Negative BacteriaBacterial Pneumonia
TTY Biopharm 480
Large-scale testing (Phase 3)Study completedNCT00128492
What this trial is testing

Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Cystic Fibrosis (CF) Patients With Pseudomonas Aeruginosa (PA)

Who this might be right for
Cystic Fibrosis
Gilead Sciences 274
Testing effectiveness (Phase 2)Study completedNCT00449644
What this trial is testing

TMC207-TiDP13-C208: Anti-bacterial Activity, Safety, and Tolerability of TMC207 in Participants With Multi-drug Resistant Mycobacterium Tuberculosis (MDR-TB).

Who this might be right for
Tuberculosis
Janssen Infectious Diseases BVBA 208
Early research (Phase 1)Looking for participantsNCT07406334
What this trial is testing

A Trial to Evaluate the Safety and Reactogenicity of an Investigational Pneumococcal Vaccine in Toddlers 12 to 15 Months of Age Receiving a Single Booster Dose

Who this might be right for
Pneumonia, Bacterial
GlaxoSmithKline 45
Not applicableStudy completedNCT00002434
What this trial is testing

Neutrexin Plus Leucovorin in the Treatment of Pneumocystis Carinii Pneumonia (PCP)

Who this might be right for
Pneumonia, Pneumocystis CariniiHIV Infections
U.S. Bioscience
Early research (Phase 1)Study completedNCT02375698
What this trial is testing

A Phase I Study of Safety & Immunogenicity of AERAS-456 in HIV-Neg. Adults Treated for Drug-susceptible Pulmonary TB

Who this might be right for
Tuberculosis
Aeras 22
Testing effectiveness (Phase 2)Ended earlyNCT01198626
What this trial is testing

Efficacy and Safety Study of JNJ-32729463 Compared With Moxifloxacin for the Treatment of Subjects Requiring Hospitalization for Community-Acquired Bacterial Pneumonia

Who this might be right for
Community-Acquired Bacterial Pneumonia (CABP)
Furiex Pharmaceuticals, Inc 32
Next Page